CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis
about
Intracellular events and cell fate in filovirus infectionLiver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.The Curious Case of Type I IFN and MxA: Tipping the Immune Balance in AIDSCritical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infectionAttenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocyclineInnate and Adaptive Immune Regulation During Chronic Viral InfectionsDissecting How CD4 T Cells Are Lost During HIV InfectionChronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interactionModeling HIV quasispecies evolutionary dynamics.HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activationPlasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients.Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.Pathogenic potential of interferon αβ in acute influenza infectionInability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection.Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells.The TRAIL of helpless CD8+ T cells in HIV infection.Interferon-alpha administration enhances CD8+ T cell activation in HIV infectionAbortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue.Three-dimensional microscopy characterization of death receptor 5 expression by over-activated human primary CD4+ T cells and apoptosis.Evidence of dysregulation of dendritic cells in primary HIV infection.Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, CameroonIn vitro HIV infection impairs the capacity of myeloid dendritic cells to induce regulatory T cells.Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.Dendritic cells in progression and pathology of HIV infection.Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells.Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis.Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.Coinfection with HIV-1 and HCV--a one-two punch.The TRAIL to viral pathogenesis: the good, the bad and the uglyPolymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals.The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious DiseasesIsolation of a TRAIL antagonist from the serum of HIV-infected patients.Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis.Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activationInterferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.New insights into type I interferon and the immunopathogenesis of persistent viral infections.Replication-independent expression of anti-apoptosis marker genes in human peripheral blood mononuclear cells infected with the wild-type HIV-1 and reverse transcriptase variants
P2860
Q22305521-BB4E26D6-144B-455E-8035-5105EA7C4A2BQ26777511-A9AD0FFE-0AC8-4F51-9B5A-3EE58940F018Q26995244-3A6A6F39-62F3-4C21-B723-3C7D80007CF1Q27318086-1AC6A6FE-4C9A-4941-ACC9-0176F1C81482Q27342233-06B7B76C-C74D-48C1-87A6-21F8DDF3DEEDQ28079717-C6F4C66E-451C-442B-A3DA-B80B67DB176EQ28274045-47385EE5-5A0F-439C-8F54-BAB0A8E4509BQ28731004-EB63FA93-5DF0-43AA-9ECE-8F89FD01A73CQ33296550-388EB143-ED38-47D6-BA82-792CA1A4568AQ33359564-015C1817-0C65-4604-B1EB-217C07BC8972Q33608661-0DCA4437-4CCF-4862-A521-1301C2786298Q33613674-97829AE0-4556-4C92-B663-6BC29C3F7E4BQ33663298-C8FF7FFB-24E6-4360-9EBE-4BB7432B2142Q33676532-684DCA76-3506-4F3F-A3E7-9D3FF3493D6FQ33941348-E8999E5D-10D3-49DD-AF03-0CA06861563FQ33992829-F71DE306-B0F7-4B7C-BD41-EFC25EE4DC5CQ34014711-C427C869-F7D1-4DF1-9287-C387567395EBQ34083271-E36FF565-9821-447E-8C51-040CEBEC5989Q34145979-C28A7D22-D7B2-4FEE-9C79-6BC70D5C0DD8Q34152017-095DC76C-8869-4197-89C9-099D90C20932Q34193462-375483FF-DCAF-4DAA-BB03-044C0F097684Q34310896-011DFD52-5322-4D4A-9688-B0076EFD248BQ34314856-FC75E439-9240-41A3-B127-0ED3A58241BEQ34388925-7C68FDEE-A462-4729-A120-8FFFC54283DDQ34557110-F36CD98B-6F4E-45FD-BDE9-E44A20A3B4C7Q34657557-F301F06B-A85F-49F6-960B-E96067BC2A81Q34664366-E09A4F9E-B099-4B44-8154-21CA13A09A6DQ34699537-74CFCFF0-2439-42D7-AFEE-5D8EEA20AFBBQ34720373-ADA59971-618E-4F1A-9D15-9EAE06C980F5Q35018048-B37C6D62-E9A6-4589-9327-DF906857750FQ35137038-58F4769D-2E0D-4142-88FE-C1FEBD41B863Q35146349-89BCCEF6-5FCC-48FD-906B-1CE0A3C8428DQ35146361-F4568ED8-A71D-42B2-A4CD-781B90352F87Q35172090-03A8A392-ECF5-4626-96AF-713153EF36BDQ35372514-CBB51270-C670-4B74-8605-B96213D41C8FQ35553567-DBF091F1-F57B-40B2-9AE5-ED525A903806Q35606616-08151AB5-3675-42BB-B40F-1F26D583B25FQ35627713-E50B9D02-536D-4502-88D3-D080E7206036Q35648751-14108950-7BB4-4C12-8F3C-05E8114F732CQ35731327-0A849F91-C897-4F9D-A72C-F6E4E32845E5
P2860
CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
CD4+ T-cell death induced by i ...... , TRAIL/DR5-mediated apoptosis
@ast
CD4+ T-cell death induced by i ...... , TRAIL/DR5-mediated apoptosis
@en
type
label
CD4+ T-cell death induced by i ...... , TRAIL/DR5-mediated apoptosis
@ast
CD4+ T-cell death induced by i ...... , TRAIL/DR5-mediated apoptosis
@en
prefLabel
CD4+ T-cell death induced by i ...... , TRAIL/DR5-mediated apoptosis
@ast
CD4+ T-cell death induced by i ...... , TRAIL/DR5-mediated apoptosis
@en
P2093
P2860
P1433
P1476
CD4+ T-cell death induced by i ...... , TRAIL/DR5-mediated apoptosis
@en
P2093
Andrew W Hardy
Claire Chougnet
Gene M Shearer
Hideo Yagita
Jean-Philippe Herbeuval
Jeffrey D Lifson
Matthew J Dolan
P2860
P304
P356
10.1182/BLOOD-2005-03-1243
P407
P577
2005-07-26T00:00:00Z